EICHORCondition: Colorectal Neoplasia · Colorectal Cancer · Sponsor: Chinese University of Hong Kong
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The primary objective of this study is to analyze the 15-year cumulative incidence of advanced colorectal neoplasia and CRC-related mortality after the index colonoscopy.
This description comes directly from the study's public registry record.
Felix Sia · +85226370428 · felix.sia@cuhk.edu.hk
Thomas Lam · +85226370428 · thomas.lam@cuhk.edu.hk
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: 1\. All patients with colonoscopy performed in HA hospitals during the study period would be eligible for screening. Exclusion Criteria: 1\. Patients with documented personal history of colorectal cancers before the study period would be excluded.
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Prince of Wales Hospital | Shatin, New Territories, Hong Kong | Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04815525